(Q44821104)

6 December 2017

title

Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma (English)

1 reference

6 December 2017

1 reference

Zhenyu Wu

1

1 reference

6 December 2017

Liang Wang

2

1 reference

6 December 2017

Gang Li

3

1 reference

6 December 2017

Hui Liu

4

1 reference

6 December 2017

Feiyan Fan

5

1 reference

6 December 2017

Zhaobo Li

6

1 reference

6 December 2017

Yunqing Li

7

1 reference

6 December 2017

Guodong Gao

8

1 reference

6 December 2017

publication date

1 December 2013

1 reference

Molecular and Cellular Biochemistry

6 December 2017

published in

1 reference

6 December 2017

volume

384

1 reference

6 December 2017

issue

1-2

1 reference

6 December 2017

page(s)

263-268

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1805-5

6 December 2017

exact match

0 references

cites work

The 2007 WHO classification of tumors of the central nervous system - what has changed?

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Radiosurgery for glioma patients: hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNA regulation by RNA-binding proteins and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNAs and the kidney: coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Identification and functional characterization of microRNAs involved in the malignant progression of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1805-5

MicroRNAs in cancers and neurodegenerative disorders

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24122417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24122417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24122417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-013-1805-5

1 reference

6 December 2017

1 reference